"Heterocyclic Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cyclic compounds that include atoms other than carbon in their ring structure.
| Descriptor ID |
D006571
|
| MeSH Number(s) |
D03
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heterocyclic Compounds".
Below are MeSH descriptors whose meaning is more specific than "Heterocyclic Compounds".
This graph shows the total number of publications written about "Heterocyclic Compounds" by people in this website by year, and whether "Heterocyclic Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heterocyclic Compounds" by people in Profiles.
-
trans-IV restriction: a new configuration for metal bis-cyclam complexes as potent CXCR4 inhibitors. Dalton Trans. 2024 Mar 19; 53(12):5616-5623.
-
Medicinal Potential of Heterocyclic Compounds from Diverse Natural Sources for the Management of Cancer. Mini Rev Med Chem. 2020; 20(11):942-957.
-
64Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist. J Nucl Med. 2020 01; 61(1):123-128.
-
The Current Status of O-Heterocycles: A Synthetic and Medicinal Overview. ChemMedChem. 2018 06 06; 13(11):1071-1087.
-
Discovery of Antischistosomal Drug Leads Based on Tetraazamacrocyclic Derivatives and Their Metal Complexes. Antimicrob Agents Chemother. 2016 09; 60(9):5331-6.
-
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer. Cancer Gene Ther. 2015 Dec; 22(12):581-90.
-
IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis. PLoS One. 2015; 10(3):e0122439.
-
Synthesis, structural studies, and oxidation catalysis of the late-first-row-transition-metal complexes of a 2-pyridylmethyl pendant-armed ethylene cross-bridged cyclam. Inorg Chem. 2015 Mar 02; 54(5):2221-34.
-
Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering. Stem Cells. 2012 Dec; 30(12):2720-31.
-
a-Tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation-induced gastrointestinal injury in mice. Exp Hematol. 2012 May; 40(5):407-17.